In vivo fluorescence imaging: success in preclinical imaging paves the way for clinical applications
A Refaat, ML Yap, G Pietersz, APG Walsh… - Journal of …, 2022 - Springer
Advances in diagnostic imaging have provided unprecedented opportunities to detect
diseases at early stages and with high reliability. Diagnostic imaging is also crucial to …
diseases at early stages and with high reliability. Diagnostic imaging is also crucial to …
Developments in the treatment of Fabry disease
SJ van der Veen, CEM Hollak… - Journal of inherited …, 2020 - Wiley Online Library
Enzyme replacement therapy (ERT) with recombinant α‐galactosidase A (r‐αGAL A) for the
treatment of Fabry disease has been available for over 15 years. Long‐term treatment may …
treatment of Fabry disease has been available for over 15 years. Long‐term treatment may …
Risk of nephrogenic systemic fibrosis in patients with stage 4 or 5 chronic kidney disease receiving a group II gadolinium-based contrast agent: a systematic review …
SA Woolen, PR Shankar, JJ Gagnier… - JAMA internal …, 2020 - jamanetwork.com
Importance Risk of nephrogenic systemic fibrosis (NSF) to individual patients with stage 4 or
5 chronic kidney disease (CKD; defined as estimated glomerular filtration rate of< 30 …
5 chronic kidney disease (CKD; defined as estimated glomerular filtration rate of< 30 …
Consensus-based technical recommendations for clinical translation of renal ASL MRI
Objectives This study aimed at developing technical recommendations for the acquisition,
processing and analysis of renal ASL data in the human kidney at 1.5 T and 3 T field …
processing and analysis of renal ASL data in the human kidney at 1.5 T and 3 T field …
Diagnostic value of alternative techniques to gadolinium-based contrast agents in MR neuroimaging—a comprehensive overview
A Falk Delgado, D Van Westen, M Nilsson… - Insights into …, 2019 - Springer
Gadolinium-based contrast agents (GBCAs) increase lesion detection and improve disease
characterization for many cerebral pathologies investigated with MRI. These agents …
characterization for many cerebral pathologies investigated with MRI. These agents …
Direct mapping of kidney function by DCE-MRI urography using a tetrazinanone organic radical contrast agent
ND Calvert, A Kirby, M Suchý, P Pallister… - Nature …, 2023 - nature.com
Chronic kidney disease (CKD) and acute kidney injury (AKI) are ongoing global health
burdens. Glomerular filtration rate (GFR) is the gold standard measure of kidney function …
burdens. Glomerular filtration rate (GFR) is the gold standard measure of kidney function …
Nephrogenic systemic fibrosis in patients with chronic kidney disease after the use of gadolinium-based contrast agents: a review for the cardiovascular imager
Gadolinium-enhanced cardiac magnetic resonance has revolutionized cardiac imaging in
the last two decades and has emerged as an essential and powerful tool for the …
the last two decades and has emerged as an essential and powerful tool for the …
Canadian Association of Radiologists recommendations for the safe use of MRI during pregnancy
P Jabehdar Maralani, A Kapadia… - Canadian …, 2022 - journals.sagepub.com
The use of magnetic resonance imaging (MRI) during pregnancy is associated with
concerns among patients and health professionals with regards to fetal safety. In this work …
concerns among patients and health professionals with regards to fetal safety. In this work …
Whole-body magnetic resonance imaging (WB-MRI) for cancer screening: Recommendations for use
G Petralia, F Zugni, PE Summers, A Colombo… - La radiologia …, 2021 - Springer
Whole-body magnetic resonance imaging (WB-MRI) is currently recommended for cancer
screening in adult and paediatric subjects with cancer predisposition syndromes …
screening in adult and paediatric subjects with cancer predisposition syndromes …
Mn (II) complex of lipophilic group-modified ethylenediaminetetraacetic acid (EDTA) as a new hepatobiliary MRI contrast agent
K Chen, P Li, C Zhu, Z Xia, Q Xia, L Zhong… - Journal of Medicinal …, 2021 - ACS Publications
Liver-specific contrast agents (CAs) can improve the Magnetic resonance imaging (MRI)
detection of focal and diffuse liver lesions by increasing the lesion-to-liver contrast. A novel …
detection of focal and diffuse liver lesions by increasing the lesion-to-liver contrast. A novel …